Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma

Laboratory Investigation

Volumn 79, Issue 7, 1999, Pages 859-867

  Soda, Takeshi ^a,e   Fujikawa, Keita ^b   Ito, Tadahiro ^c   Sasaki, Miharu ^c   Nishio, Yasunori ^d   Miyakawa, Mieko ^a  

^a SHIMADA MUNICIPAL HOSPITAL   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

^d SHIZUOKA GENERAL HOSPITAL   (Japan)

^e KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL NUCLEUS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032788285     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Artacho-Perula E, Roldan-Villalobos R, Lopez-Rubio F, and Vaamonde-Lemos R (1992). Stereological estimates of nuclear volume in carcinoma of the ampulla of Vater. Histopathology 21:241-248.
2. deKernion JB and Belldegrun A (1992). Renal tumors. In: Walsh PC, Retik AB, Stamey TA, and Vaughan ED Jr, editors. Campbell's urology, 6th ed. Philadelphia: W. B. Saunders, 1053-1093.
3. Fujikawa K, Sasaki M, Aoyama T, and Itoh T (1995a). Prognostic criteria in patients with stage D2 prostate cancer. Correlation with mean nuclear volume. Cancer 76:91-95.
4. Fujikawa K, Sasaki M, Aoyama T, and Itoh T (1997a). Role of volume weighted mean nuclear volume for predicting disease outcome in patients with renal cell carcinoma. J Urol 157: 1237-1241.
5. Fujikawa K, Sasaki M, Aoyama T, Itoh T, and Yoshida O (1995b). Prognostic criteria in patients with prostate cancer: Correlation with volume weighted mean nuclear volume. J Urol 154:2123-2127.
6. Fujikawa K, Sasaki M, Arai Y, Yamabe H, Ogawa O, and Yoshida O (1997b). Prognostic criteria in patients with prostate cancer - Gleason score versus volume-weighted mean nuclear volume. Clin Cancer Res 3:613-618.
7. Gelb AB (1997). Renal cell carcinoma: Current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 981-986.
8. Goldstein NS (1997). The current state of renal cell carcinoma grading. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:977-980.
9. Gundersen HJG and Jensen EB (1983). Particle sizes and their distributions estimated from line- and point-sampled intercepts: Including graphical unfolding. J Microsc 131:291-310.
10. Gundersen HJG and Jensen EB (1985). Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J Microsc 127-142.
11. Gutierrez JL, Val BJ, Garijo MF, Buelta L, and Portillo JA (1992). Nuclear morphometry in prognosis of renal adenocarcinoma. Urology 39:130-134.
12. Hermanek P and Sobin LH (1987). TNM classification of malignant tumors, 4th ed. New York: Springer-Verlag, 136-138.
13. Mostofi FK, Sesterhenn IA, and Sobin LH (1981). Histological typing of kidney tumors. Geneva: World Health Organization.
14. Murphy GF, Partin AW, Maygarden SJ, and Mohler JL (1990). Nuclear shape analysis for assessment of prognosis in renal cell carcinoma. J Urol 143:1103-1107.
15. Pound CR, Partin AW, Epstein JI, Simons JW, and Marshall FF (1993). Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. Urology 42:243-248.
16. Robson CJ, Churchill BM, and Anderson W (1969). The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297-301.
17. Sasaki M, Sorensen FB, Fukuzawa S, Yamabe H, Olsen S, and Yoshida O (1993). Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder. Cancer 72:2470-2483.
18. Skinner DG, Vermillion CD, and Colvin RB (1972). The surgical management of renal cell carcinoma. J Urol 107:705-710.
19. Sorensen FB (1989). Objective histopathologic grading of cutaneous malignant melanomas by stereologic estimation of nuclear volume. Prediction of survival and disease-free period. Cancer 63:1784-1798.
20. Sorensen FB (1991). Stereological estimation of the mean and variance of nuclear volume from vertical sections. J Microsc 203-229.
21. Sorensen FB (1992). Quantitative analysis of nuclear size for objective malignancy grading: A review with emphasis on new, unbiased stereologic methods. Lab Invest 66:4-23.
22. Sorensen FB, Bichel P, and Jakobsen A (1992). DNA level and stereologic estimates of nuclear volume in squamous cell carcinomas of the uterine cervix. A comparative study with analysis of prognostic impact. Cancer 69:187-199.
23. Sorensen FB, Sasaki M, Fukuzawa S, Yamabe H, Olsen S, and Yoshida O (1994). Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility. Lab Invest 70:242-254.
24. Tosi P, Luzi P, Baak JP, Miracco C, Santopietro R, Vindigni C, Mattei FM, Acconcia A, and Massai MR (1986). Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma. Cancer 58:2512-2518.
25. Yorukoglu K, Aktas S, Guler C, Sade M, and Kirkali Z (1998). Volume-weighted mean nuclear volume in renal cell carcinoma. Urology 52:44-47.